QQ客服 官方微博 反馈留言

	An ovarian cancer model with positive ER: Reversion of ER antagonist resistance by Src blockade
	Li, Long; Li, Xiaojun; Han, Xiaobing; Yang, Ting; Fu, Jing; Zhang, Yunfeng; Gou, Wenli
刊名	ONCOLOGY REPORTS
	2014
卷号	32期号:[db:dc_citation_issue]页码:943-950
关键词	ovarian cancer fulvestrant saracatinib resistance
ISSN号	1021-335X
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3289555
专题	西安交通大学
推荐引用方式 GB/T 7714	Li, Long,Li, Xiaojun,Han, Xiaobing,et al. An ovarian cancer model with positive ER: Reversion of ER antagonist resistance by Src blockade[J]. ONCOLOGY REPORTS,2014,32([db:dc_citation_issue]):943-950.
APA	Li, Long.,Li, Xiaojun.,Han, Xiaobing.,Yang, Ting.,Fu, Jing.,...&Gou, Wenli.(2014).An ovarian cancer model with positive ER: Reversion of ER antagonist resistance by Src blockade.ONCOLOGY REPORTS,32([db:dc_citation_issue]),943-950.
MLA	Li, Long,et al."An ovarian cancer model with positive ER: Reversion of ER antagonist resistance by Src blockade".ONCOLOGY REPORTS 32.[db:dc_citation_issue](2014):943-950.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。